4//SEC Filing
Hwang Kuk Hyoun 4
Accession 0000898432-23-000125
CIK 0001840425other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:31 PM ET
Size
6.9 KB
Accession
0000898432-23-000125
Insider Transaction Report
Form 4
Hwang Kuk Hyoun
DirectorPresident and CEO10% Owner
Transactions
- Other
Common Stock
2023-02-21+225,000→ 2,025,000 total(indirect: By LLC) - Other
Common Stock
2023-02-21−4,500→ 2,020,500 total(indirect: By LLC)
Footnotes (3)
- [F1]Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC the sponsor of the Issuer (the "Sponsor"), whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
- [F2]Represents the shares that will no longer be forfeited by the Sponsor as a result of the underwriters exercising the over-allotment option in full.
- [F3]Represents an additional 4,500 shares that were transferred from the Sponsor to the underwriters as a result of the underwriters exercising the over-allotment option in full.
Documents
Issuer
Bellevue Life Sciences Acquisition Corp.
CIK 0001840425
Entity typeother
Related Parties
1- filerCIK 0001953660
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:31 PM ET
- Size
- 6.9 KB